Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BAX

What to Expect From Baxter International's Q2 2025 Earnings Report

Baxter International is expected to release its second-quarter earnings next month, with analysts anticipating a low double-digit profit decline.

Barchart

Is Baxter International Stock Underperforming the Nasdaq?

Baxter International has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Baxter Dury enters his brat era: 'I want to escape the trap of mature man music'

Baxter Dury’s new album Allbarone is a dancefloor filler resulting from a love of Charli xcx and a producer who wouldn’t listen to him

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

What Are Wall Street Analysts' Target Price for Baxter International Stock?

Although Baxter International has underperformed the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

Giro d'Abruzzo: Georg Zimmermann wins final GC as Ivo Oliveira scores another stage victory

Oliveira attacks with Sjoerd Bax but peloton keeps them close

Cycling News

Here's What to Expect From Baxter International’s Next Earnings Report

As Baxter International approaches its first-quarter earnings report early next month, analysts are forecasting a double-digit decline in profits.

Barchart

Is Baxter International Stock Underperforming the S&P 500?

Despite its underperformance over the past year, Baxter International has notably outpaced the S&P 500 in the recent months and analysts remain cautiously optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Baxter International Stock: Is Wall Street Bullish or Bearish?

Baxter International has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Earnings Preview: What To Expect From Baxter International's Report

As Baxter International prepares to report its fourth-quarter earnings next month, analysts expect a double-digit profit dip.

Barchart

How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks?

Baxter International has lagged behind its peers in the medical devices industry over the past three months, and analysts are cautious about the stock's prospects.

Barchart

Baxter International Stock: Analyst Estimates & Ratings

Due to Baxter International’s underperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Baxter International's Quarterly Earnings Preview: What You Need to Know

Baxter International is all set to announce its third-quarter results next month, with analysts predicting a double-digit growth in the company's earnings.

Barchart

Baxter Stock: Is BAX Underperforming the Healthcare Sector?

Baxter has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq?

Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 High-Growth MedTech Stocks to Buy

The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading.

Barchart

Do Wall Street Analysts Like Baxter International Stock?

As Baxter International has underperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's prospects.

Barchart

Baxter International's Q2 2024 Earnings: What to Expect

Baxter International is poised to release its second-quarter results this month, and analysts are projecting a double-digit earnings growth.

StockNews.com

3 Growth Stocks With P/E Ratios Below Industry Average

Growth stocks trading at lower P/E ratio than the industry average can be a suitable investment choice. Top picks now could be Cardinal Health (CAH), Baxter International (BAX), and DocuSign (DOCU). Keep reading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Becton, Dickinson and Company Stock Underperforming the S&P 500?

Becton, Dickinson and Company has lagged the S&P 500 recently, but analysts are optimistic about the stock’s prospects.

Barchart

Baxter International Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Baxter International’s relatively underwhelming performance over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Benzinga

Analyst Ratings for Baxter Intl

Analysts have provided the following ratings for Baxter Intl (NYSE:BAX) within the last quarter:

Benzinga

Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook

Baxter International Inc (NYSE:BAX) has posted Q1 revenue of $3.71 billion, beating the consensus of $3.68 billion, up 26% on a reported basis, 29% on a constant currency basis, and 3% on an operational basis. Adjusted EPS of $0.93 increased 22%, ahead of the consensus of $0.80. Baxter's newly acquired Hillrom businesses…

Benzinga

Recap: Baxter Intl Q1 Earnings

Baxter Intl (NYSE:BAX) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

Benzinga

Death Cross Looms Over Baxter Intl Investors

If history is any guide, there may be trouble ahead for shares of Baxter Intl (NYSE:BAX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

FDA Issues To Class I Recall To Baxter's Spectrum Infusion Pump

In December 2021, Baxter International Inc (NYSE: BAX) issued an urgent safety communication about an issue with some of its Spectrum infusion pumps.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Becton, Dickinson, and Company

Zimmer Biomet Holdings

16 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.